ReviewExperimental & molecular medicine2026
PARP inhibitors and breast cancer: from therapeutic breakthrough to resistance challenge.
Weiyun Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it